Late-onset carbamoyl phosphate synthetase 1 deficiency in an adult cured by liver transplantation

Liver Transplantation

Volumn 17, Issue 12, 2011, Pages 1481-1484

  Bates, Timothy R ^a,b   Lewis, Barry D ^c   Burnett, John R ^b,d,e   So, Kenji ^f   Mitchell, Andrew ^f   Delriviere, Luc ^f   Jeffrey, Gary P ^b,f  

^a Swan District Hospital   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT DISEASE; ARTICLE; BRAIN DISEASE; CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY; CASE REPORT; HUMAN; HYPERAMMONEMIA; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RARE DISEASE; STROKE; TREATMENT OUTCOME; UREA CYCLE DISORDER; WORK RESUMPTION;

AGE OF ONSET; BRAIN DISEASES, METABOLIC; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); HUMANS; HYPERAMMONEMIA; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME; UREA CYCLE DISORDERS, INBORN;

EID: 82455175741     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22407     Document Type: Article

References (21)

1. Brusilow SW, Horwich AL,. Urea enzymes. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Molecular and Metabolic Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001: 1909-1965.
2. Braissant O,. Current concepts in the pathogenesis of urea cycle disorders. Mol Genet Metab 2010; 100 (suppl 1): S3-S12.
3. Walker V,. Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab 2009; 11: 823-835.
4. LaBuzetta JN, Yao JZ, Bourque DL, Zivin J,. Adult nonhepatic hyperammonemia: a case report and differential diagnosis. Am J Med 2010; 123: 885-891.
5. Martínez AI, Pérez-Arellano I, Pekkala S, Barcelona B, Cervera J,. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. Mol Genet Metab 2010; 101: 311-323.
6. Pekkala S, Martínez AI, Barcelona B, Yefimenko I, Finckh U, Rubio V, Cervera J,. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis. Hum Mutat 2010; 31: 801-808.
7. Haraguchi Y, Uchino T, Takiguchi M, Endo F, Mori M, Matsuda I,. Cloning and sequence of a cDNA encoding human carbamyl phosphate synthetase I: molecular analysis of hyperammonemia. Gene 1991; 107: 335-340.
8. Summar ML, Hall LD, Eeds AM, Hutcheson HB, Kuo AN, Willis AS, et al. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene. Gene 2003; 311: 51-57. (Pubitemid 36830801)
9. Verbiest HB, Straver JS, Colombo JP, van der Vijver JC, van Woerkom TC,. Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma. Acta Neurol Scand 1992; 86: 275-279.
10. Lo WD, Sloan HR, Sotos JF, Klinger RJ,. Late clinical presentation of partial carbamyl phosphate synthetase I deficiency. Am J Dis Child 1993; 147: 267-269. (Pubitemid 23077281)
11. Wong LJ, Craigen WJ, O'Brien WE,. Postpartum coma and death due to carbamoyl-phosphate synthetase I deficiency. Ann Intern Med 1994; 120: 216-217. (Pubitemid 24038806)
12. Eather G, Coman D, Lander C, McGill J,. Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-year-old. J Clin Neurosci 2006; 13: 702-706. (Pubitemid 44066806)
13. Kotani Y, Shiota M, Umemoto M, Tsuritani M, Hoshiai H,. Carbamyl phosphate synthetase deficiency and postpartum hyperammonemia. Am J Obstet Gynecol 2010; 203: e10-e11.
14. Takeoka M, Soman TB, Shih VE, Caviness VS Jr, Krishnamoorthy KS,. Carbamyl phosphate synthetase 1 deficiency: a destructive encephalopathy. Pediatr Neurol 2001; 24: 193-199. (Pubitemid 32294267)
15. British Inherited Metabolic Disease Group. Emergency guidelines. Accessed August 2011.
16. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A,. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 2007; 356: 2282-2292. (Pubitemid 46849158)
17. Leonard JV, McKiernan PJ,. The role of liver transplantation in urea cycle disorders. Mol Genet Metab 2004; 81 (suppl 1): S74-S78. (Pubitemid 38402239)
18. Morioka D, Kasahara M, Takada Y, Shirouzu Y, Taira K, Sakamoto S, et al. Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 2005; 11: 1332-1342. (Pubitemid 43071582)
19. Moini M, Mistry P, Schilsky ML,. Liver transplantation for inherited metabolic disorders of the liver. Curr Opin Organ Transplant 2010; 15: 269-276.
20. Meyburg J, Hoffmann GF,. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab 2010; 100 (suppl 1): S77-S83.
21. Kasahara M, Sakamoto S, Shigeta T, Fukuda A, Kosaki R, Nakazawa A, et al. Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency. Pediatr Transplant 2010; 14: 1036-1040.